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Using a selection for spontaneous mutants that mislocalize a vacuolar carboxypeptidase Y (CPY)-invertase
fusion protein to the cell surface, we identified vacuolar protein targeting (vpt) mutants in 25 new vpt
complementation groups. Additional alleles in each of the eight previously identified vpt complementation
groups (vptl through vpt8) were also obtained. Representative alleles from each of the 33 vpt complementation
groups (vptl through vpt33) were shown to exhibit defects in the sorting and processing of several native
vacuolar proteins, including the soluble hydrolases CPY, proteinase A, and proteinase B. Of the 33
complementation groups, 19 were found to contain mutant alleles that led to extreme defects. In these mutants,
CPY accumulated in its Golgi complex-modified precursor form which was secreted by the mutant cells.
Normal protein secretion appeared to be unaffected in the vpt mutants. The lack of significant leakage of
cytosolic markers from the vpt mutant cells indicated that the vacuolar protein-sorting defects associated with
these mutants do not result from cell lysis. In addition, the observation that the precursor rather than the
mature forms of CPY, proteinase A, proteinase B were secreted from the vpt mutants was consistent with the
fact that mislocalization occurred at a stage after Golgi complex-specific modification, but before final vacuolar
sorting of these enzymes. Vacuolar membrane protein sorting appeared to be unaffected in the majority of the
vpt mutants. However, a subset of the vpt mutants (vptll, vptl6, vptl8, and vpt33) was found to exhibit defects
in the sorting of a vacuolar membrane marker enzyme, a-mannosidase. Up to 50% of the oa-mannosidase
enzyme activity was found to be mislocalized to the cell surface in these vpt mutants. Seven of the vpt
complementation groups (vpt3, vptll, vptl5, vptl6, vptl8, vpt29, and vpt33) contained alleles that led to a
conditional lethal phenotype; the mutants were temperature sensitive for vegetative cell growth. This
temperature-sensitive phenotype has been shown to be recessive and to cosegregate with the vacuolar
protein-sorting defect in each case. Tetrad analysis showed that vpt3 mapped to the right arm of chromosome
XV and that vptl5 mapped to the right arm of chromosome II. Intercrosses with other mutants that exhibited
defects in vacuolar protein sorting or function (vpl, sec, pep, and end mutants) revealed several overlaps among
these different sets of genes. Together, these data indicate that more than 50 gene products are involved,
directly or indirectly, in the process of vacuolar protein sorting.
A basic and fundamental question in biology is that of how
a cell is constructed spatially from the information encoded
by its genes and from maternally inherited cues and struc-
tures. This spatially segregated cellular organization is crit-
ical for normal cell functioning. To understand the process,
it is important to know not only how the cytoskeletal
elements fit together and define the overall shape and struc-
ture of the cell but also how proteins, structural and other-
wise, find their way to appropriate locations within the cell.
An analysis of the assembly and maintenance of each
organelle individually could provide a view of the mecha-
nism underlying the cellular construction process.
Protein sorting to mammalian lysosomes represents one of
the best-characterized protein delivery pathways (19, 37).
Much is known about the route that is followed by lysosomal
enzymes, and a few components of the sorting machinery
have been characterized at the biochemical and molecular
levels. However, this is a complex process and we still lack
a detailed understanding of the molecular mechanisms un-
derlying this sorting pathway. We chose to work on protein
sorting to the yeast equivalent of the mammalian lysosome,
the vacuole. The yeast Saccharomyces cerevisiae is the
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organism of choice because we wished to take a genetic
approach to solving the vacuolar protein targeting problem.
The vacuole is an acidic compartment that is involved in
amino acid and inorganic ion storage, as well as various
degradative and nutrient recycling functions, especially un-
der starvation conditions (20, 43). It contains a variety of
hydrolytic enzymes, including the soluble glycoproteins
carboxypeptidase Y (CPY), proteinase A (PrA), and protein-
ase B (PrB), and several membrane-bound enzymes, includ-
ing an a-mannosidase, a proton-translocating ATPase, di-
peptidylaminopeptidase B, and several permeases (43, 44).
Vacuolar proteins transit along with proteins destined for
secretion through the early stages of the secretory pathway
(38). The transport of the luminal enzymes CPY and PrA has
been studied in the greatest detail (18, 18a, 35a). Each of
these enzymes is synthesized initially as an inactive pre-
proenzyme that is translocated into the lumen of the endo-
plasmic reticulum, where the transient N-terminal signal
peptide is removed and the proteins are modified with an
N-linked core oligosaccharide (12). These intermediate pre-
cursor forms are referred to as plCPY and plPrA. The pl
forms are then delivered to the Golgi complex, where further
glycosyl modifications convert them to larger p2 forms. At
this stage, it is presumed that proteins on their way to the
vacuole are sorted from other secretory proteins destined for
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secretion or assembly into the plasma membrane (9, 11, 38).
Vesicular carriers are presumed to mediate Golgi complex-
vacuole transfer of these enzymes. At present there is no
evidence concerning the existence of an intermediate com-
partment between the Golgi complex and the vacuole in S.
cerevisiae analogous to the endosomal compartment de-
tected in mammalian cells. Just prior to, or more likely upon,
arrival in the vacuole, the p2 forms of CPY and PrA are
proteolytically cleaved to their mature forms (22, 23). This
proteolytic maturation is dependent on the presence of
active vacuolar PrA, and involves the removal of N-terminal
prosegments from each protein (13). Similarly, other vacuo-
lar enzymes such as PrB also appear to be made and
transported in their precursor forms and to undergo PrA-
dependent proteolytic maturation in the vacuole (21, 22; C.
Moehle, C. K. Dickxon, and E. Jones, J. Cell Biol., in
press).
The observations that mutations in the CPY vacuole
sorting signal or high gene dosage-induced overproduction of
CPY and PrA lead to missorting and secretion of these
proteins indicate that a failure to sort vacuolar proteins
results in their delivery to the cell surface (15, 39, 41). This
rationale was used by Rothman and Stevens (35) to identify
mutants that were defective in vacuolar protein sorting by
isolating yeast strains that secreted CPY. Through this
approach, they identified mutants that were assigned to eight
complementation groups (referred to as vpl, for vacuolar
protein localization-defective mutants). Independently, we
used a gene fusion-based selection scheme to isolate mutants
defective in vacuolar protein targeting (vpt) (2). By this
approach, mutants defective in the vacuolar sorting of a
CPY-invertase (Inv) hybrid protein (CPY-Inv433) (15) were
selected. Eight vpt complementation groups were identified
and shown to missort and secrete the CPY-Inv hybrid
protein as well as the wild-type CPY protein (2). The
advantages of the Inv fusion approach include the following.
(i) The identification of mutants is not dependent on their
secretion of active CPY; (ii) the gene fusion approach, in
theory, could be applied to any vacuolar protein whether its
biochemical activity was known or not; and (iii) the absence
or presence of external Inv activity can be easily assayed,
and powerful genetic selection procedures have been devel-
oped that demand the presence of external Inv activity.
In this study we greatly extended the gene fusion approach
to isolate and biochemically characterize some 500 new vpt
mutants. Here we describe the genetic and biochemical
analysis of these vacuolar protein-targeting mutants. Our
results indicate that many different gene functions partici-
pate in the events associated with normal vacuolar protein
sorting. This process is likely to involve several distinct
steps, including the selective recognition of vacuolar pro-
teins, their packaging into transport vesicles, delivery of
these vesicles to the correct target organelle, recognition and
fusion with the target, release of the vacuolar proteins, and
recycling of transport components for additional rounds of
protein sorting.
MATERIALS AND METHODS
Yeast strains. S. cerevisiae SEY6210 (MATot leu2-3,112
ura3-52 his3-,200 trpl-A901 lys2-801 suc2-A9 GAL) and
SEY6211 (MATa leu2-3,112 ura3-52 his3-A200 trpl-A901
ade2-101 suc2-A9 GAL) were constructed by standard ge-
netic methods (36). Both strains contained a complete dele-
tion (suc2-A9) of the chromosomal copy of SUC2 and
contained no other unlinked Inv structural genes (7).
SEY6210 and SEY6211 were transformed to uracil indepen-
dence with either of two CPY-Inv fusion-encoding plasmids,
pCYI-50 and pCYI-433 (15). vpt mutant alleles vptl-J
through vpt8-1 (2) in the SEY2101 (MATa ura3-52 leu2-3,112
suc2-A9 ade2-101) (7) strain background were used for
complementation tests with new vpt mutants isolated in
strain SEY6210 (this study). They were also crossed with
strain SEY6210 to give MATaL lys2-801 vptl-J through vpt8-1
strains for crossing with new vpt mutants isolated from
SEY6211.
Media and genetic methods. YPD medium, minimal yeast
medium, sporulation medium, and bromocresol purple indi-
cator plates were prepared as described previously (36). The
bromocresol purple plates contained 2% sucrose as the sole
carbon source and were spread with 0.2 mg of antimycin A
in 95% ethanol just before use (2). The minimal medium of
Wickerham (42), which was modified as described previ-
ously (15), was used for cell growth before and during
labeling with Na35SO4 (ICN Radiochemicals). Standard ge-
netic methods (36) were used throughout this study. Replica
plating to test phenotypes of segregants was done with a
48-pronged replicator by using dilution in sterile 96-well
microtiter dishes (24). Rapid complementation analysis was
carried out by using the pronged replicator to transfer arrays
of 48 new vpt mutants to microtiter dishes containing vpt
tester strains of the opposite mating type suspended in liquid
YPD medium. Mating and diploid growth were allowed to
occur in the wells for 2 days at 26°C. Replicas were then
made onto minimal medium, which was supplemented to
select for diploid strains. The resulting patches of diploid
strains were transferred without dilution to YP fructose and
assayed for external Inv activity by using a rapid filter
replica assay method (15, 18) to score complementation.
Enzyme assays. The procedures and unit definitions used
for assays of invertase and a-glucosidase (15), CPY (39), PrA
(1), a-mannosidase (28), and glyceraldehyde-3-phosphate
dehydrogenase (Worthington Enzyme Manual; Worthington
Diagnostic, Freehold, N.J.) (3) have been described previ-
ously.
Labeling, fractionation, and immunoprecipitation. Sphero-
plasts were prepared and labeled by a modification of a
previously described method (32). Cells were grown to the
mid-log phase in the minimal medium of Wickerham (42) that
was supplemented with 0.2% yeast extract. Four units of
cells at an optical density at 600 nm were then centrifuged
and suspended in 0.1 M Tris sulfate (pH 9.4)-10 mM
dithiothreitol and incubated at 30°C for 5 min, centrifuged
again, and suspended in the minimal medium of Wickerham
(42) that was adjusted to pH 7.4 and that contained 1.3 M
sorbitol. Lyticase was added to a final activity of 30 U per
optical density unit at 600 nm, and the cultures were incu-
bated at 30°C for 20 min to remove the cell wall. Sphero-
plasts were pelleted, suspended in the minimal medium of
Wickerham (42) containing 1.3 M sorbitol, and labeled with
Tran35S label (0.2 mCi/ml) for 20 min at 30°C. Chase was
initiated by the addition of methionine (final concentration,
50 ,ug/ml). The labeled culture was separated into sphero-
plast (intracellular) and medium (extracellular) fractions. To
examine proteins in the medium fraction, cells were grown
and labeled as described previously (15). The whole cells
were then separated from the medium fraction by centrifu-
gation, precipitated with 5% trichloroacetic acid, suspended
in loading buffer, and run on sodium dodecylsulfate-10%
polyacrylamide gels. Antisera to PrA, CPY, and Inv were
prepared as described previously (18a).
Materials. Lyticase was obtained from Enzogenetics,
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Tran35S label was from ICN Radiochemicals and all other
chemicals were from Sigma Chemical Co. (St. Louis, Mo.).
Antiserum to PrB was a gift from C. Moehle and E. Jones.
RESULTS
Isolation of 25 new vpt complementation groups. Previ-
ously, we observed that short amino-terminal domains of the
CPY sequence, when fused to mature enzymatically active
Inv, can quantitatively divert delivery of this normally
secreted enzyme to the yeast vacuole (15). Yeast cells
require external Inv activity to grow on sucrose as a sole
fermentable carbon source, so we could exploit the sorting
behavior of the CPY-Inv hybrid protein to select mutants
that missort and secrete the fusion protein. Yeast strains
deleted for all endogenous genes encoding invertase (Asuc)
but containing a low-copy-number (CENIV, ARSI) plasmid
encoding an appropriate CPY-Inv hybrid protein as their
only source of Inv activity could not grow on sucrose,
because all the Inv activity was sequestered in the vacuole
(Fig. 1). Suc+ derivatives of such cells can be isolated simply
by selecting for growth on sucrose-containing medium.
Based on earlier results, many of these mutants were ex-
pected to mislocalize the native vacuolar enzyme CPY as
well, because targeting of the fusion proteins to the vacuole
is dependent on the presence of the CPY vacuolar sorting
signal at the amino-terminal end of the CPY-Inv hybrid
proteins (15). In the present study, we decided to select such
mutants using two different CPY-Inv hybrid proteins: CPY-
InvSO (encoded by plasmid pCYI-50) and CPY-Inv433 (en-
coded by plasmid pCYI-433) (Fig. 1). These gene fusions
were composed of the coding sequence for the N-terminal 50
and 433 amino acids of proCPY, respectively, which were
fused in-frame to a truncated form of the SUC2 gene carried
on the Escherichia coli-S. cerevisiae shuttle vector
pSEYC306 (15). This modified SUC2 gene lacked its 5'-
regulatory sequences and the coding sequence for its amino-
terminal signal peptide (15) (Fig. 1).
Suc+ mutant strains were isolated from the Asuc2 strains
SEY6210 and SEY6211 harboring either pCYI-50 or pCYI-
433. To select Suc+ mutants, single colonies of the four
parental strains were plated onto YP medium with sucrose as
the sole carbon source, antimycin A as an inhibitor of
respiration, and bromocresol purple as a pH indicator;
bromocresol purple turns yellow when sucrose is being
fermented. Only one spontaneous mutant derived from each
parental colony was picked, to ensure that each mutation
event was independent. A total of 505 Suc+ mutants were
obtained and characterized: 241 MATa Suc+ vpt mutants
(isolated from SEY6211) and 264 MATa Suc+ vpt mutants
(isolated from SEY6210). We confirmed that these vpt mu-
tants secreted the CPY-Inv hybrid protein by carrying out a
rapid filter assay for external Inv activity. This assay in-
volved patching the mutants onto YP plates containing
fructose, incubating the plates at 26°C for 24 to 36 h, and
then making replicas onto Whatman no. 1 filter papers
(Whatman, Inc., Clifton; N.J.) that were presoaked in an Inv
assay solution (15, 18). External Inv reacted with the assay
mixture to produce a red spot at the position of the appro-
priate cell patch. The presence of internal Inv activity was
confirmed by exposing the cell patches to chloroform vapor,
which lyses the yeast cells, prior to transfer onto the assay
filter. This simple method permitted us to get an initial
indication of the extent of the mislocalization defect for each
new vpt mutant. All of the vpt mutants were found to express
external Inv activity by this assay. In the parental control
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FIG. 1. Selection scheme for vpt mutants. (A) PRC1-SUC2 gene
fusions encoding CPY-Inv hybrid proteins. At the top is a schematic
representation of the gene encoding CPY (PRCI). The signal se-
quence is indicated by a solid black box, the prosegment is indicated
by hatched lines, and the mature sequences are indicated by dots
(15). The positions of the oligosacchande addition sites are indicated
by tadpole-shaped forms. The two fusions of PRCI sequences to
SUC2 used to select vpt mutants are shown below. The 50-amino-
acid fusion received extensive glycosyl modification, whereas the
433-amino-acid fusion did not become hyperglycosylated. (B) The
gene encoding PrA (PEP4) and a representation of the PEP4-SUC2
gene fusion tested for its localization in the vpt mutants (Table 1).
(C) A simple diagram showing the vacuolar protein delivery route
followed by the CPY-Inv hybrid protein (C-I). The vpt mutants were
selected for their mislocalization of some or all of this CPY-Inv
hybrid protein to the cell surface. For some of the vpt mutants,
secretion of the mislocalized CPY-Inv was shown to be dependent
on SEC] gene function, indicating that delivery to the surface is
mediated by secretory vesicles (2). ER, Endoplasmic reticulum; aa,
amino acid; PM, plasma membrane.
strains, all of the Inv activity was internal, as determined by
the assay.
The Inv filter assay was also used to determine whether
the vpt mutations were dominant or recessive in diploid
strains derived by backcrossing each of the vpt mutants to
the appropriate parental strain (SEY6210 or SEY6211).
Recessive vpt mutants were then intercrossed, diploid
strains were isolated, and the filter assay was used to assign
the MATa vpt x MATa vpt strains to complementation
groups (Fig. 2). Complementing pairs of recessive vpt mu-
tants exhibited no external Inv activity (white patch on Inv
filter assays), whereas noncomplementing pairs of vpt mu-
tants gave rise to red patches on the filters corresponding to
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FIG. 2. Complementation analysis of vpt mutants. Secreted Inv
activity of intact cells. Diploids were constructed by crossing vpt
MATa lys2 with vpt MATa ade2 mutants and selecting Ade+ Lys'
diploid strains on minimal medium. These diploid strains were
patched in an array onto YP medium containing fructose and
screened by the Inv filter assay. Noncomplementation was seen as
a red spot, indicating secretion of the CPY-Inv hybrid protein, while
complementation was observed as no reaction (white).
the secretion of Inv activity. In general, the assay gave
unambiguous results, as shown in Fig. 2. Of the 505 new vpt
mutants, 17 were found to contain mutations that led to a
dominant Suc+ phenotype. Of six of these dominant mutants
tested, only one was found to harbor a mutation linked to the
fusion plasmid. The other mutants apparently contained
dominant chromosomal mutations. These have not yet been
characterized further. The remaining 488 mutants contained
recessive mutations. Of these, 184 (84 MATa and 100 MATa)
could be assigned to the previously identified vpt comple-
mentation groups (vptl through vpt8) (2). The remaining
MATa vpt mutants were systematically crossed with new
MATa vpt mutants until they could be assigned to new
complementation groups (arbitrarily defined as containing
one MATa and one MATa allele). Twenty-five new vpt
complementation groups were identified (vpt9 through vpt33)
(Table 1). Mutant alleles in each of the 33 complementation
groups identified were obtained with both the pCYI-50 and
the pCYI-433 fusion plasmids. A total of 21 recessive MATa
vpt mutants and 36 recessive MATa vpt mutants were
crossed with at least one allele from each of the 33 vpt
complementation groups and, in addition, were crossed with
all the remaining unassigned vpt mutants of the opposite
mating type. All 21 unassigned MATa mutants comple-
mented each of the remaining 36 unassigned MATa vpt
mutants. We did not construct MATa and MATa alleles of
each of these 57 unassigned vpt mutants and continue the
complementation analysis further.
Because the vpt mutants were selected as spontaneous
events, we expected that they would correspond to single-
site mutations. To obtain further support of this, many of the
vpt mutants (vpt3, vpt4, vpt7, vpt9, vptll, vptl4, vptl5,
vptl6, vptl8, vpt29, and vpt33) were crossed with parental
VPT strains and subjected to tetrad analysis. For each
mutant tested, the vpt defect and all the other markers
scored in the cross segregated with the expected 2:2 Men-
delian inheritance pattern of simple single-locus mutations.
This confirmed that these vpt mutants represent single-site
changes and further indicated that the genetic defects asso-
ciated with these mutants do not result in any gross mating
or chromosomal abnormalities. In the course of these anal-
yses, we noticed that two of the vpt mutants appeared to be
linked to auxotrophic markers that were heterozygous in the
crosses. The segregation data for vpt3 and ade2 (17 parental
ditype:1 tetratype:O nonparental ditype) indicated that vpt3
was linked to ade2. The approximate map distance (calcu-
lated as described previously [36]) between ade2 and vpt3
was -2.8 centimorgans. This locates the VPT3 locus on the
right arm of chromosome XV, where ADE2 has been
mapped (25). Another of the vpt mutants, vptl5, appeared to
be linked to lys2 (17 parental ditype:5 tetratype:0 nonpa-
rental ditype), in this case less tightly (-11.4 centimorgans).
The L YS2 gene has been mapped to the right arm of
chromosome 11 (25).
Mislocalization of vacuolar enzymes in the vpt mutants. At
least one mutant from each of the 33 vpt complementation
groups was subjected to a series of enzyme assays to
quantitate the extent of the mislocalization defect and to test
whether mislocalization of the CPY-Inv fusion protein was
due to cell lysis.
The extent of mislocalization of the CPY-Inv hybrid
protein was determined for several alleles of each comple-
mentation group by assaying external Inv (in whole cells) as
well as total Inv (in lysed cells) and then calculating the
percentage of Inv activity that was secreted (15). The results
obtained for a representative vpt mutant allele from each
complementation group are presented in Table 1. In most
cases other alleles from the same complementation group
secreted the CPY-Inv hybrid protein to a similar extent. Two
to five alleles from each vpt complementation group were
assayed. The alleles for which assay data are shown in Table
1 were used in all subsequent analyses.
The most obvious unrelated defect that might lead to the
apparent secretion of vacuolar proteins is cell lysis. For this
reason, assays of a cytoplasmic marker enzyme, glyceral-
dehyde-3-phosphate dehydrogenase, were carried out to
determine whether any of the vpt mutants exhibited signifi-
cant levels of external glyceraldehyde-3-phosphate dehydro-
genase activity. In no case was there evidence of significant
leakage of this cytoplasmic marker enzyme into an extracel-
lular fraction. Furthermore, the level of cell-associated gly-
ceraldehyde-3-phosphate dehydrogenase activity detected
after detergent lysis of vpt mutant cells was similar to that
detected in the parental strains (SEY6210 and SEY6211)
(Table 1). In addition, the mutants were tested for the
presence of external ot-glucosidase, another cytoplasmic
enzyme. Again, no evidence for lysis was found (data not
shown). As discussed below, the vpt mutants secreted
precursor forms of the vacuolar proteins rather than the
mature forms, as would have been expected if cell lysis were
responsible for the observed secretion.
As an initial crude test to determine whether the new vpt
mutants also secrete CPY, we assayed CPY enzyme activity
in each mutant. Since CPY is normally processed from the
inactive p2 zymogen to the mature, active form inside the
vacuole, it is expected that if CPY is missorted into the
media, it will not become activated or will be activated
poorly (38, 39). Thus, the more extreme the vpt mislocaliza-
tion defect, the lower the cell-associated CPY activity is
expected to be relative to the activities of the parental strains
SEY6210 and SEY6211. CPY activity levels ranged from 2%
of parental activity in vptS up to 82% in vpt23 (Table 1). CPY
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TABLE 1. vpt complementation groups and enzyme assay dataa
Complementation Total no. No. of % CPY-Inv % of parent % PrA-Inv % External % External
groups of alleles ts alleles secreted CPY activity secreted G3PDH a-mannosidase
vptl 46 85 10 45 5 <5
vpt2 29 25 65 ND ND ND
vpt3 11 1 80 10 75 <5 <5
vpt4 15 75 5 65 <5 <5
vptS 9 100 <5 65 <5 5
vpt6 6 70 5 45 <5 <5
vpt7 32 90 30 55 <5 10
vpt8 33 65 25 65 <5 <5
vpt9 20 65 35 55 <5 <5
vptlO 29 50 30 35 <5 20
vptll 8 2 90 10 60 <5 25
vptl2 3 65 70 55 <5 <5
vptl3 26 100 25 110 <5 10
vptl4 8 50 45 35 <5 15
vptl5 14 8 80 25 65 5 20
vptl6 5 2 75 10 60 <5 30
vptl7 40 80 20 65 <5 <5
vptl8 8 3 100 30 90 <5 30
vptl9 16 80 20 100 <5 <5
vpt2O 5 35 75 30 5 5
vpt2l 2 85 45 105 <5 5
vpt22 4 35 50 25 <5 <5
vpt23 25 80 30 <5 <5
vpt24 8 40 50 50 <5 10
vpt25 4 35 50 30 5 <5
vpt26 4 95 15 70 <5 15
vpt27 9 40 40 40 <5 20
vpt28 7 35 65 40 <5 5
vpt29 8 2 70 15 90 <5 10
vpt3O 4 60 40 70 <5 5
vpt3l 2 15 65 30 <5 5
vpt32 5 35 55 35 <5 5
vpt33 7 5 90 10 85 <5 20
VPT+ 5 100 5 <5 <5
a The vpt mutants were assigned to 33 complementation groups on the basis of standard complementation analysis. Also shown is the number of
temperature-sensitive vpt mutants in each of the seven complementation groups that had Ts alleles. Inv assays were performed on several alleles of each
complementation group. Whole cells were assayed for external Inv activity, and lysed cells were assayed for total Inv activity. The percentage of external Inv
activity was calculated for each mutant allele. A strongly defective allele (high extracellular percentage of Inv) was chosen for further analysis. Levels of other
enzyme activities secreted by, or associated with, these representative alleles are presented. Abbreviations: G3PDH, glyceraldehyde-3-phosphate dehydrogenase;
ND, not determined.
activities were inversely proportional to the level of the
CPY-Inv hybrid protein secreted from most of the vpt
mutants (Table 2). For example, some mutants such as vptS
and vpt33 were very defective by both criteria, whereas
others, including vpt2 and vpt2O, did not show major defects
by either assay. This result indicates that the behavior of the
CPY-Inv hybrid protein in the vpt mutants accurately re-
flects the effect that these mutations have on CPY activity
and, presumably, on its localization.
The availability of PrA-Inv hybrid proteins that were
efficiently targeted to the vacuole (Fig. 1) (18, 18a) offered a
simple way for us to test the effect of vpt mutations on the
localization of another protein that is found in the vacuole in
wild-type yeast. To this end, the representative vpt alleles
were cured of the plasmids encoding CPY-Inv fusions and
retransformed with a vector (pP4I-404) encoding a fusion
protein, PrA-Inv404, consisting of the N-terminal 404 amino
acids of PrA fused to mature active Inv. The hybrid protein
expressed by pP4I-404 is delivered efficiently to the vacuole
in S. cerevisiae VPT strains (18a). Inv assays showed that in
most of the vpt mutants significant amounts of PrA-Inv
hybrid protein were secreted instead of being targeted to the
TABLE 2. Grouping of vpt mutants based on CPY and CPY-Inv localizationa
% of CPY-Inv vpt complementation group with the following CPY activities (% of parent):
activity secreted <15% 15-30% 30-50% >50%
>90% 5, 26, 33 7, 13, 18
65-90% 1, 3, 4, 6, 11, 16 15, 17, 19, 29 21
40-65% 8, 10 9, 30, 14, 24 12
<40% 27 2, 20, 22, 23, 25, 28, 31, 32
a Grouping of vpt mutants based on severity of CPY and CPY-Inv fusion protein localization defects. The percentage of CPY enzyme activity was broken into
four levels, as was the percentage of CPY-Inv hybrid protein secreted. The 33 vpt complementation group numbers are shown in the appropriate spaces. vpt
mutants that showed severe mislocalization defects, processing defects, or both types of defect for both CPY and PrA, as shown by cell fractionation and
immunoprecipitation of these proteins (Fig. 3), are given in boldface.
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FIG. 3. Immunoprecipitation of CPY and PrA in wild-type (SEY6210 and SEY6211) and vpt mutant yeast strains. Spheroplasts were
labeled (as described in the text) and chased for the indicated times (in minutes). The spheroplast pellet made up the internal (I) fraction and
the supernatant constituted the external (E) fraction in each case. Immunoprecipitations were carried out with CPY or PrA antisera.
Densitometer tracings were used to calculate the approximate percentages of CPY and PrA in the internal and external fractions for each
mutant shown. The vpt mutants with similar phenotypes to those shown are listed. Distribution patterns of CPY and PrA for vptl, vpt3, vpt4,
vpt6, vpt7, and vpt30 ranged between those shown for vpt5 and vpt17. The migration positions of precursor and mature forms of CPY (mCPY)
and PrA (mPrA) and their approximate molecular sizes (in kilodaltons [kd]) are indicated. For many of the mutants a protein form intermediate
in size between p2CPY and mature CPY was immunoprecipitated by anti-CPY antisera. This band migrated at approximately the same
position as plCPY on our gels. The pl and p2 forms of PrA could not be resolved under the gel conditions used.
vacuole (Table 1). The most defective vpt mutants, as
estimated by the reduction in CPY activity levels and
secretion of the CPY-Inv hybrid proteins, were also the
mutants that exhibited the largest defects in PrA-Inv sorting
(Table 1). It is possible that both PrA and CPY use a
common delivery pathway.
We were also interested in determining whether, in addi-
tion to the sorting of soluble vacuolar hydrolases, sorting of
vacuolar membrane proteins was affected in any of the vpt
mutants. One vacuolar membrane enzyme that has been well
characterized is a-mannosidase. This enzyme is not depen-
dent on PrA processing for its activation (17), and thus
would be expected to remain active even when it was
mislocalized (to the cell surface, for example). The vpt
mutants were tested for the presence of cell surface a-
mannosidase activity by assaying whole, as well as deter-
gent-lysed, cells. In all of the vpt mutants, total a-manno-
sidase activity levels were comparable to that of the wild
type (VP1). The only vpt mutants that showed significant
levels of external cell-associated a-mannosidase activity
were vptJO, vptll, vptl5, vptl6, vptl8, vpt27, and vpt33
(Table 1). It is interesting that these mutants, with the
exception of vptlO and vpt27, were severely defective by
several other criteria, including CPY and PrA mislocaliza-
tion (Fig. 3), and the possession of additional phenotypes
such as temperature sensitivity (Table 1) and abnormal
vacuolar morphology (L. M. Banta, J. S. Robinson, D. J.
Klionsky, and S. D. Emr, J. Cell. Biol., in press). All of the
representative vpt alleles shown in Table 1 were non-tem-
perature-sensitive alleles. To further address the a-manno-
sidase localization defect, we also assayed the potentially
more severe temperature-sensitive (Ts) alleles of each com-
plementation group for which they were available (vptll,
vptlS, vpt16, vpt18, and vpt33). Interestingly, we observed
as much as 40 to 50% of the a-mannosidase activity at the
cell surface in some Ts alleles of vptll, vpt16, vpt18, and
vpt33, even when the cells were grown at the permissive
growth temperature (25°C). No evidence for cell lysis of the
Ts alleles was obtained.
We suspected that some of the vpt mutants might secrete
an altered spectrum of proteins compared with that of
wild-type S. cerevisiae for two reasons. First, since secre-
tory and vacuolar proteins transit together through portions
of the secretory pathway (38), some gene products affecting
the delivery of molecules to the vacuole might also affect the
transport of other molecules destined for secretion. Thus, if
the vpt mutations affected the secretion pathway, some
extracellular proteins might be missing or reduced in the
medium isolated from certain of the vpt mutant strains.
Second, and conversely, additional protein species may
accumulate in the growth medium, since the vpt mutants
were selected for their ability to secrete vacuolar contents.
To address these questions, we examined the secretion of
radioactively labeled proteins by some vpt mutants into the
growth medium. Cells were labeled with 35S04 for 20 min
and then chased for 20 min in the presence of excess
unlabeled SO4. Media proteins were precipitated in tri-
chloroacetic acid, resolved by sodium dodecyl sulfate-poly-
acrylamide gel electrophoresis, and examined by autoradi-
ography (Fig. 4). No striking differences between the media
fractions isolated from wild-type or vpt mutant cells were
observed. Comparable amounts of a similar set of proteins
were observed in extracts from both wild-type and vpt
mutant cells. Two of the mutants (vpt7 and vptll) exhibited
an extra protein band, in addition to the set observed in VPT
S. cerevisiae (Fig. 4). We did not determine whether either
of these new bands corresponded to a known vacuolar
protein. Based on their apparent molecular weights, these
proteins were not CPY or PrA. Because we analyzed the
medium from pulse-labeled cells, we also inferred that the
rate of normal protein secretion was not grossly altered in
the vpl mutants. The lack of new proteins corresponding to
CPY or PrA in the medium was probably due to the
instability of these mislocalized proteins (2, 38), as well as to
their relatively low abundance compared with that of the
proteins in the medium observed under these experimental
conditions.
In addition, many of the mutants were transformed with
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FIG. 4. Proteins secreted from wild-type and vpt mutant strains.
Strains were labeled with 3QSO4 for 20 min and chased for 20 min
with (NH4)2SO4 (1 mM). Cells were removed by centrifugation. The
supernatant (medium) proteins were precipitated with trichloroace-
tic acid and run on a 10% polyacrylamide gel. Size standards (in
kilodaltons [kd]) are as indicated.
an Inv-encoding plasmid (pRB58) and tested for normal Inv
secretion (assay and calculations were as described pre-
viously [27]). The vpt mutants were found to secrete Inv at
the same levels as wide-type S. cerevisiae. This provides
further evidence that the vpt mutants carry out secretion
normally.
vpt mutants exhibit defects in the sorting and processing of
several vacuolar proteins. To assess directly the extent of the
sorting defect in the various vpt mutants, we labeled and
fractionated vpt mutant cells. Antisera directed against CPY,
PrA, and PrB were used to detect the amount and form of
these different vacuolar proteins in each cell fraction. Ini-
tially, cells were labeled and fractionated into medium,
periplasm, and spheroplast fractions, with subsequent im-
munoprecipitation by anti-CPY and anti-PrA antisera. These
data (not shown) allowed us to categorize the vpt mutants
based on the severity of their CPY and PrA localization and
processing defects. However, we noticed that during the
fractionation, presumably because of the incubation time
required to remove the cell wall enzymatically, some frac-
tion of these proteins was being degraded or modified. To
avoid this, we converted the mutant cells to spheroplasts
before they were labeled and fractionated. In this way we
were able to look at mislocalization by isolating spheroplast
(pellet) and medium fractions by centrifugation. The medium
fraction corresponded to all material secreted from the cells,
including those proteins that are normally retained in the
periplasm. A further advantage of labeling spheroplasts is
that because lysed spheroplasts do not incorporate the label,
it reduces the background of labeled vacuolar proteins in the
medium resulting from cell lysis during spheroplast prepara-
tion. To confirm that the spheroplast-labeling technique did
not alter normal protein secretion or protein sorting to the
vacuole, we initially analyzed the modification and process-
ing of the secreted enzyme (Inv) and the vacuolar proteins
(CPY and PrA) in spheroplasts prepared from a wild-type
strain. Both protein secretion and vacuolar protein sorting
and processing appeared to be normal (Fig. 3 and 5). Indeed,
we observed that the level of protein expression and the
kinetics of protein modification and delivery appeared to be
normal by the spheroplast-labeling technique (8, 15, 18, 35b).
This argues that secretory protein traffic occurs normally in
yeast spheroplasts.
Wild-type and vpt mutant spheroplasts were labeled with
[35S]methionine for 20 min and chased with cold methionine
Chase: 01
Fraction: I E I
Mature [
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FIG. 5. Immunoprecipitation of Inv from labeled spheroplasts.
VPT S. cerevisiae (SEY6211) containing the Inv-encoding plasmid
pRB58 was derepressed by growth in 0.1% glucose for 30 min,
converted to spheroplasts, and labeled for 5 min with [35S]methio-
nine. Chase with cold methionine was for 0, 3, or 7 min, as
indicated. Spheroplasts were separated into pellet (I) and superna-
tant (E) fractions by centrifugation and immunoprecipitated with Inv
antisera. The core glycosylated Inv found in the endoplasmic
reticulum (E.R.) migrated as a set of bands that were converted to a
heterogeneous mixture of highly glycosylated molecules in the Golgi
complex prior to secretion from the cell. kd, Kilodaltons.
for 30 min. Supernatant (external) and pellet (internal) frac-
tions were immunoprecipitated with anti-CPY antisera. We
observed two significant effects of the vpt mutants on the
biogenesis of the vacuolar protein CPY (Fig. 3). First,
processing was altered; 14 of the mutants exhibited no
mature CPY at all (vptl, vpt3, vpt4, vptS, vpt6, vpt7, vptll,
vptl5, vptl6, vptl7, vpt18, vpt29, vpt3O, vpt33), and an
additional 5 vpt mutants processed less than 30% of CPY to
the mature forms (vpt8, vpt9, vptl3, vptl9, vpt26). Second,
missorting and secretion of CPY were observed. Two of the
vpt mutants (vptlS and vpt29) secreted more than 95% of
CPY into the periplasmic and medium fraction. An addi-
tional 12 vpt mutants (vptl, vpt3, vpt4, vptS, vpt6, vpt7,
vptll, vptl6, vptl7, vptl8, vpt3O, vpt33) were almost as
defective; they secreted between 60 and 80% of CPY (Fig.
3). These 14 most defective mutants exhibited a complete
defect in maturation of the small amount of CPY that
remained associated with the spheroplast fraction, as dis-
cussed above, indicating that the accumulated proCPY was
not sorted to the vacuole or, possibly, that the vacuole of
these mutants was so defective that it was not competent for
the processing of proCPY. Many of the remaining vpt
mutants exhibited less severe defects in the sorting of the
CPY protein. In these mutants, a substantial portion ofCPY
remained associated with the spheroplast and was processed
to the mature active enzyme, indicating that some of the
proCPY was sorted correctly to the vacuole (Fig. 3).
To determine whether this protein-sorting defect is spe-
cific for CPY or extends to other vacuolar proteins, we
examined sorting and processing of two additional vacuolar
proteins, PrA and PrB, in the vpt mutants. Relative to CPY,
lower levels of both PrA and PrB were secreted by the vpt
mutants. However, we noted that the extent of the defect in
maturation of these proteins paralleled that observed for
CPY in each of the vpt mutants (Fig. 3 and 6). The absence
of CPY in the vacuole cannot explain the accumulation of
precursor forms of PrA and PrB, as maturation of these
proteases is not dependent on CPY function. This suggests
that the defect in vacuolar sorting of PrA and PrB may be
similar to that observed for CPY, but that secretion of the
missorted PrA and PrB is blocked. We reasoned that the
reduced level of proPrA and proPrB in the media fraction
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FIG. 6. Immunoprecipitation of PrB in wild-type (SEY6210 and SEY6211) and vpt mutant yeast strains. Spheroplasts were labeled as
described in the text and chased for the indicated times (in minutes). I, Internal (spheroplast pellet) fraction; E, external (supernatant)
fraction. PrB antiserum was used for the immunoprecipitations. The migration positions of precursor (proPrB) and mature (mPrB) forms of
PrB and their approximate molecular sizes (in kilodaltons [kd]) are indicated. Note the extra band at 0 min; presumably, it was an intermediate
in PrB maturation.
might be due to a reduced rate in secretion of these missort-
ed proteins. To address this possibility, we extended the
length of the chase period from 30 to 90 min and otherwise
performed the fractionation and immunoprecipitation proce-
dures as described above. When this experiment was carried
out on vptS, vptfl1, and vptlS, no increases in the levels of
proPrA or proPrB were observed in the medium after this
extended chase period (data not shown). In this experiment
we also observed that no additional processing of the proPrA
and proPrB occurred during the chase.
An alternative explanation is that the lack of these pro-
teins in the medium fraction might not be due to a block in
secretion of the mislocalized zymogens, but rather to the
specific or nonspecific association of these proteins with the
spheroplast membrane surface. To test this possibility, we
treated the labeled spheroplasts with 500 pLg of proteinase K
per ml for 30 min at O0C to determine whether any of the
cell-associated proPrA and proPrB was accessible to the
exogenously added protease. Several vpt mutants (vptS,
vptl7, and vpt26) were analyzed in this way, and in each
case, PrA and PrB were unaffected by the addition of
proteinase K. As expected, secreted CPY was degraded
under these conditions. Both PrA and PrB were, however,
subject to degradation if the detergent Triton X-100 (1%) was
added prior to protease addition. Taken together, these
experiments indicate that proPrA and proPrB accumulate in
some intracellular compartment. The present data do not
rule out the vacuole as the site in which these proteins
reside; however, the lack of processing of the accumulated
proteins suggests that this may not be case. This lack of
processing does not eliminate the vacuole as the site of
accumulation of PrA and PrB, because of the observation
that in missense PrA mutants, CPY activity is normal but
PrA activity is decreased (23).
Several vpt mutants are temperature sensitive for growth. It
is not clear whether vacuolar protein sorting is essential for
yeast cell growth. The pep4 mutants (45) are defective in
enzyme activities of many soluble vacuolar hydrolases, yet
they grow normally at all temperatures. We selected our
mutants at 260C to allow us to score for potential tempera-
ture-conditional phenotypes. Thus, after the mutants were
selected for their ability to grow on sucrose-containing
medium at 260C, they were tested for their ability to grow at
370C on YPD medium. Of the 505 mutants isolated, 23
(approximately 5%) were Ts for growth at 370C (i.e., they did
not form colonies at 370C). These Ts mutants belonged to six
vpt complementation groups (vptll, vptl5, vptl6, vpt 18,
vpt29, and vpt33). In addition, one allele of vpt3 had a partial
Ts phenotype (very small colonies at 370C). Genetic crosses
and tetrad analysis were used to confirm that in each case the
Ts phenotype cosegregated with the vpt protein sorting
defect. One Ts allele from each complementation group was
crossed to the parent strain (SEY6210 or SEY6211), sporu-
lated, and subjected to tetrad dissection. Ten or more tetrads
were examined for each cross (an example of the cosegre-
gating phenotypes is shown in Fig. 7). The remaining Ts
alleles in a given complementation group were inferred to be
linked to the appropriate vpt locus by complementation
testing at 370C. It is interesting that of the vpt complemen-
tation groups that contained Ts alleles (not including ypt3),
22 of 50 total alleles (i.e., 44%) in these complementation
groups were Ts. Thus, the Ts alleles are not scattered at
Total Inv Activit
YPD (26C (L.ysed Cells)
FIG. 7. Demonstration that the Ts growth phenotype and the vpt
mislocalization phenotype cosegregate in four representative tetrads
from a cross of a Ts allele of vptl6 with strain SEY6210. The filter
assay of the lysed segregant patches showed that each spore had Inv
activity. Below, the Inv filter assay of intact segregant patches
showed that the ability to secrete Inv activity (i.e., the CPY-Inv
hybrid protein) segregated 2:2. Similar cosegregation of the Ts and
vpt defects was seen for ypt3, vptll, yptlS, vptl8, vpt29, and ypt33.
At least 10 tetrads were analyzed in each case.
- 42kd
-33kd
VOL. 8, 1988
E I E I E I E
4944 ROBINSON ET AL.
random throughout the total set of vpt complementation
groups. In addition, the complementation groups which
possess Ts alleles all tend to exhibit more severe defects by
several criteria. These defects include missorting of vacuolar
proteins, sensitivity to high osmotic pressure, and inability
to assemble morphologically normal vacuoles (Banta et al.,
in press).
As described above, the Ts vpt mutants exhibited a
vacuolar protein-sorting defect at the permissive growth
temperature. We examined the Ts alleles at the restrictive
temperature to see whether the transport defect was exag-
gerated further and thereby might explain their inviability at
37°C. The mutants were preincubated for 60 min at 37°C and
then labeled for 20 min with 35S04 and chased for 20 min,
both at 37°C. Immunoprecipitation with CPY antibody
showed that there was no apparent difference in CPY
processing or secretion at the restrictive temperature (data
not shown), but it should be noted that all of these Ts vpt
mutants exhibited extreme defects in vacuolar protein sort-
ing, even at the permissive temperature. Since the Ts vpt
mutants secreted Inv at 37°C, secretion apparently is not
blocked at this temperature (see below). Because the defect
in CPY sorting and processing was nearly complete even at
the permissive growth temperature, the absence of growth at
the nonpermissive temperature may be explained by the
appearance of a more complete sorting defect at the high
temperature, which alters the sorting of additional vacuolar
proteins and possibly also affects secreted proteins that are
essential for growth. Alternately, it may be that the com-
bined stress of growth at a high temperature together with a
defect in vacuolar protein sorting may, in an additive fash-
ion, prevent cell growth at 37°C. For example, it is possible
that a loss of vacuole protein localization at a high temper-
ature may result in a block in secretion or endocytosis, or
both, since these defects have been shown to be lethal (27,
34). To address these questions, the Ts vpt mutants were
tested in several ways for possible secretory or endocytic
defects. First, the Ts vpt mutants were transformed with a
plasmid (pRB58) carrying the entire wild-type structural
gene and regulatory sequences of SUC2 and tested for Inv
secretion at restrictive and permissive temperatures. For the
experiment at the restrictive temperature, cells were shifted
to 37°C for 60 or 120 min prior to the assay. Activities in
whole and lysed cells were measured and compared to
determine the percentage of Inv secreted (27). The mutants
that were tested were not found to be significantly different
from the parental strain SEY6210 harboring the same SUC2
plasmid (data not shown). This implies that the Ts vpt
mutants do not exhibit an Inv secretion defect at 37°C.
Second, the Ts vpt mutants were tested for genetic overlap
with the Ts secretion-defective mutants secl-sec23 (27) and
sec53 (10). The sec mutants are defective for the secretion of
Inv at 37°C and are blocked for transport at various stages of
the secretory pathway in S. cerevisiae (26). sec x vpt diploid
strains were selected and tested for complementation of the
temperature sensitivity at 37°C. In each case complementa-
tion was observed, implying that there is no genetic overlap
between these two sets of mutants. The Ts vpt mutants were
also crossed with the Ts endocytosis-defective mutant end]
(5). Diploid strains were again tested for Ts growth defects.
It was found that vptll did not complement end], implying
that these two mutants are allelic to one another. In addition,
the END) gene (a gift from H. Riezman) was found to rescue
the Ts defect of the vptll allele tested (P. Herman, unpub-
lished data). This genetic overlap raises the possibility that
some of the vpt mutants may have a defect in endocytosis,
possibly at the restrictive temperature, as discussed above.
Overlap between the vpt and vpl mutants. Independent of
our vpt mutant screen, Rothman and Stevens (35) have also
isolated mutants that are defective in vacuolar protein local-
ization, vpll through vpl8. Recently, they extended this
work and selected new vpl mutants and assigned them to 11
new vpl complementation groups (T. Stevens, personal
communication). Intercrosses of the vpt mutants with all the
vpl mutants allowed us to determine the overlap between
these two sets of presumably related mutants. Each of the
vpl mutants (vpll through vpll9) was crossed with our Suc-
parental strain, diploid strains were selected and sporulated,
and Suc- vpl segregants were identified. These Asuc vpl
mutants were then crossed to representative vpt mutant
alleles from each complementation group, which harbored
the CPY-Inv433 hybrid protein-encoding plasmid. Misloca-
lization of the hybrid protein from the diploid strains was
scored by Inv filter assays. The results of these complemen-
tation studies are shown in Table 3. We observed that 12 of
the 33 vpt mutants overlapped with vpl complementation
groups. This overlap was confined in most cases to vpt
complementation groups with the less severe vacuolar pro-
tein localization defects (Table 1 and 3). At present, we do
not have an explanation for this observation. Differences in
the selection schemes used or in the starting strains may
have affected in part the final set of mutants obtained. J. H.
Rothman and T. H. Stevens (unpublished data) have used
another complementation assay technique and have inde-
pendently confirmed each of these results. To avoid future
confusion regarding these two classes of mutants, we have
decided to use the general term vps for vacuolar protein
sorting to describe both classes of mutants (Table 3).
Some differences were seen between vpl and vpt mutants
in terms of the levels of missorting of vacuolar proteins. For
example, vptS and vplS were in the same complementation
group (vpsS). The vpIS allele analyzed by Rothman and
Stevens (35) showed a weaker protein sorting defect for CPY
and PrA than did vpt5 (2) (Fig. 3). This result may indicate
allele differences. However, since the two mutations were in
unrelated genetic backgrounds, the discrepancy also could
be due to strain background differences.
Another class of pleiotropic mutants, the pep mutants,
also has been shown to affect vacuolar protein processing
(16, 17). Complementation analysis has shown that there is
genetic overlap between subsets of the pep, vpt, and vpl
mutants (T. Stevens and E. Jones, personal communica-
tion). The overlap between the vpt and pep mutants is as
follows: vpt3 = pep2l, vpt4 = pep8, vptS = peplO, vptll =
pepS, vptl3 = pep12, and vptl7 = pep6.
DISCUSSION
In an effort to identify additional mutants that exhibit
novel defects in vacuolar protein sorting and to develop an
appreciation for the number of gene functions that may
contribute to this process, we exploited a CPY-Inv fusion-
based selection scheme (2) to isolate more than 500 new vpt
mutants. The mutants were assigned to 33 different comple-
mentation groups, 7 of which contained Ts alleles. Even
though this was an unexpectedly large number of comple-
mentation groups, our data suggest that many additional
gene functions are likely to influence the vacuolar protein
delivery pathway. Several of the newly isolated vpt mutants
could not be assigned to any of these 33 complementation
groups. In addition, genetic comparison of the vpt mutants
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TABLE 3. Complementation analysis of vpt and vpl mutants
vpt vpl Common complementation
mutant mutant group name
vpt26 vpIl vpsl
vpl2 vps2
vptl7 vpl3 vps3
vptlO vpl4 vps4
vpt5 vplS vpsS
vptl3 vpl6 vps6
vpI7 vps7
vpt8 vpl8 vps8
vpt9 vps9
vptl vpslO
vptll vpI9 vpsll
vptl2 vpsl2
vpt2 vpsl3
vptl4 vpsl4
vptlS vpslS
vptl6 vpsl6
vpt3 vpsl7
vptl8 vpsl8
vptl9 vpsl9
vpt2O vpllO vps2O
vpt2l vps2l
vpt22 vpll4 vps22
vpt23 vpIl5 vps23
vpt24 vps24
vpt25 vpIl2 vps25
vpt4 vps26
vpt27 vps27
vpt28 vpIl3 vps28
vpt6 vps29
vpt3O vps3O
vpt3l vps3l
vpt32 vps32
vpt33 vps33
vpt29 vps34
vpt7 vps35
vplJl vps36
vpIJ6 vps37
vplJ7 vps38
vpll8 vps39
vpIl9 vps4O
a The vpt mutants were crossed with the vpl mutants (that had been made
Asuc2 by crossing them with strain SEY6210) and tested for their ability to
complement the CPY-Inv433 sorting defect. Extensive overlapping was seen,
and it is proposed that to avoid confusion in the future, these strains should be
referred to as vps mutants (for vacuolar protein sorting) and the numbers
should be as listed here (see also J. H. Rothman and T. H. Stevens,
manuscript in preparation).
with similar mutants from other laboratories (sec, pep, vpl,
end [5, 10, 16, 27, 35]), affecting secretory protein delivery or
processing, indicated that although there was overlap among
some of these different sets of mutants, more than 50 gene
functions are implicated in the vacuolar protein sorting
process.
This large number of genes can be interpreted to indicate
that vacuolar protein sorting is a very complex process
involving a series of distinct and precisely controlled sorting
events. These include translocation into the endoplasmic
reticulum, sorting to and through the Golgi complex, sepa-
ration from proteins destined for secretion or Golgi complex
retention, and selective delivery to the vacuole, possibly via
an intermediate endosomelike compartment. Because each
of these steps is likely to be catalyzed by proteins that are
reused through several rounds of protein transfer, any mu-
tations that affect their level of expression, stability, activity,
or ability to recycle back to the appropriate compartment of
action may lead to sorting defects. Alternatively, the large
number of mutants identified may suggest that many unre-
lated physiological and cellular defects can interfere with
vacuolar protein sorting by indirectly influencing the pro-
cess. That the former argument (that the vpt mutations cause
specific changes in the targeting machinery) may indeed be
the case for the more defective vpt mutants is supported by
the following observations. (i) All of the late-acting sec
mutants, which exhibited major defects in protein secretion,
did not alter the delivery or maturation of CPY (38). (ii)
Yeast strains deleted for the gene encoding the clathrin
heavy chain did not exhibit defects in vacuolar protein
biogenesis, even though the growth rate and intracellular
morphology of these mutants were dramatically different
from those of wild-type cells (29, 30). (iii) Cell fractionation
and enzyme assay data ruled out the release of vacuolar
proteins as a consequence of yeast cell lysis. (iv) Though
many of the vpt mutants exhibited major defects in the
targeting and maturation of vacuolar proteins, protein secre-
tion as well as many other cell functions, including cell
division, mating, and respiratory growth, remained largely
unaffected. Direct evidence concerning the specificity of the
events affected by the vpt mutants depends on the identifi-
cation of the various VPT gene products, their site of action
in the cell, and their individual biochemical activities.
Several observations led us to suspect that if vacuolar
enzymes were not efficiently targeted to the vacuole, they
would appear in the medium. Both CPY and PrA travel
through the initial part of the secretory pathway (38,
Klionsky et al., in press), so it can be postulated that if CPY
or PrA fails to be diverted to the vacuole at the appropriate
step, they might continue to be carried through the secretory
pathway and end up at the cell surface. Indeed, much
evidence has accumulated suggesting that many proteins are
secreted by a default mechanism, while vacuolar and lyso-
somal enzymes must be actively sorted away from these
proteins (4, 31). In addition, gene dosage-induced overpro-
duction of CPY or PrA or mutational changes in the vacuolar
sorting signals of these proteins lead to their missorting and
secretion (15, 18a, 39, 41), suggesting that if the vacuolar
targeting apparatus is overloaded or unable to recognize
vacuolar proteins, the default reaction for these proteins is
secretion. A similar overproduction-induced mislocalization
phenotype has been observed for the vacuolar CPY-Inv and
PrA-Inv hybrid proteins (2, 18a). Finally, an initial set of
vacuolar protein mislocalization mutants which missort and
secrete vacuolar enzymes has already been obtained by this
scheme (2, 35).
The vpt mutants were selected on the basis of their ability
to missort and secrete a hybrid vacuolar protein, CPY-Inv.
The sorting of the artificial hybrid protein CPY-Inv fairly
accurately reflects the sorting of the native CPY protein.
Several lines of evidence support this conclusion. CPY-Inv
hybrid proteins, carrying the CPY sorting signal, are very
efficiently localized to the vacuole, as is true for native CPY
(15, 18a). Mutants selected as defective in the vacuolar
sorting of CPY-Inv hybrid proteins (vpt) also exhibit similar
defects in the sorting of wild-type CPY (2). Enzyme assay
data from this and previous studies (2) demonstrate that the
extent of mislocalization of both the CPY-Inv hybrid pro-
teins and native CPY protein correlate closely in each of the
vpt mutants (Table 2). The vpt mutants genetically over-
lapped with the vpl mutants, which were selected by an
independent scheme for defects in CPY sorting (35) (Table
3). The gene fusion approach also offers the advantage that it
can be generally applied to the study of other gene products
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independent of any knowledge of their biochemical activity
(6, 7, 14).
It is of interest that although the extents of the sorting
defects seen in different vpt mutants may vary, each mutant
individually appears to exhibit qualitatively similar defects in
the sorting and processing of the three proteins that were
analyzed: CPY, PrA, and PrB. Although the vpt mutants did
not secrete the same level of proCPY, proPrA, or proPrB,
they all appeared to exhibit similar proteolytic processing
defects for each of these proteins (Fig. 3 and 6). The vpt
mutants caused significantly higher levels of proCPY to be
mislocalized to the medium than the levels observed for
either proPrA or proPrB. Most of the vpt mutants secreted
p2CPY forms, indicating that this protein passes correctly
through the Golgi complex. Although some level of secretion
of proPrA and proPrB was observed in many of the vpt
mutants, the bulk of each of these precursor proteins ap-
peared to accumulate in an intracellular compartment dis-
tinct from the vacuole. They remained associated with the
spheroplast cell fraction and were not degraded when extra-
cellular proteases were added to the labeled spheroplasts.
The proteins accumulated in their precursor forms, even
though in many vpt mutants mature forms were also present,
indicating that the vacuoles of these mutants were still
competent for precursor maturation (Fig. 3 and 6). We do
not know where in the cells the precursors accumulated or
why they were not secreted like proCPY. The PrA-Inv
hybrid protein was efficiently secreted by many of the vpt
mutants (Table 1), suggesting that PrA itself is missorted in
the mutants but cannot transit through later stages of the
secretory pathway as efficiently as the PrA-Inv hybrid pro-
tein can. (Inv is normally secreted by S. cerevisiae and may
facilitate transit of the PrA-Inv hybrid.) proPrA and proPrB
may associate specifically or nonspecifically with some
component of an intracellular membrane, or they may be
diverted into a compartment that does not communicate with
the cell surface. The vacuolar protein-sorting signals in both
proCPY and proPrA have been identified, but they appear to
share no significant primary sequence similarities (15, 18, 41)
and therefore may be recognized by different carrier sys-
tems.
An important unresolved question regarding protein sort-
ing to mammalian lysosomes or to the yeast vacuole is
whether luminal proteins transit together with integral mem-
brane proteins, and if so, does a common sorting apparatus
participate in directing the delivery of these two distinct sets
of proteins? In the case of I-cell disease, many lysosomal
luminal enzymes are missorted; however, certain membrane
proteins continue to be faithfully sorted to the vacuole (33,
37, 40). When we assayed for the location of the vacuolar
membrane marker enzyme a-mannosidase, we found that it
was not mislocalized to the cell surface in most of the vpt
mutants. Vacuoles isolated from two of these mutants (vpt3
and vpt4) retained normal levels of this enzyme activity (2).
However, a small subset of the vpt mutants did exhibit
significant defects in the sorting of a-mannosidase activity.
Alleles of vptll, vpt16, vptl8, and vpt33 secreted up to 50%
of their a-mannosidase activity to the cell surface. Interest-
ingly, this same set of vpt mutants also exhibited other
phenotypes that were consistent with the fact that these
mutants have defects in both luminal and membrane vacuo-
lar protein sorting. These phenotypes include the absence of
a detectable vacuole in the mutant cells, as determined by
light or electron microscopy, and accumulation of novel
membrane-enclosed structures that may correspond to inter-
mediates in vacuole membrane biogenesis (Banta et al., in
press). These results indicate that at least some vacuolar
membrane proteins may share a common sorting step or
compartment with soluble vacuolar proteins en route to the
vacuole.
A useful observation is that seven of the vpt complemen-
tation groups had alleles exhibiting a Ts growth defect (on
YPD medium at 37°C). In each case, this Ts growth defect
was shown to be genetically linked to the vpt phenotype. It
is probably not coincidental that these mutants all exhibited
interesting additional vacuole-related defects. These Ts vpt
mutants could be divided into three groups on the basis of
their additional phenotypes and characteristics. (i) vptlS and
vpt29 were the two complementation groups with the most
severe localization defect for CPY and PrA (Fig. 3). In
addition, they both exhibited abnormal morphologies, in-
cluding the accumulation of vesicular and Golgi complex-
related structures, and apparently enlarged vacuoles relative
to wild-type S. cerevisiae (Banta et al., in press). (ii) vptll,
vptl6, vptl8, and vpt33 also exhibited severe defects in the
sorting of CPY and showed the accumulation of most of their
PrA in the precursor form, indicating that it probably also
did not reach the vacuole. These mutants exhibited the most
striking structural defects of any of the vpt mutants, since
they did not contain a morphologically identifiable vacuole.
(iii) vpt3 had one Ts allele and was moderately defective in
CPY and PrA localization, as assessed by immunoprecipita-
tion (Fig. 3). The vpt3 mutant is interesting morphologically
because it appears to contain highly fragmented vacuoles
(Banta et al., in press).
One of the vpt mutants (vptll) was found to be allelic to
the Ts endocytosis-defective mutant endi (5). This observa-
tion is interesting because it provides the first genetic evi-
dence for a link between the endocytotic and biosynthetic
delivery routes to the yeast vacuole. This result was not
unexpected, because some mutants defective in the secre-
tory pathway (sec) are also defective in endocytosis (34), and
as discussed above, early stages of vacuolar protein target-
ing are sec dependent (38). It will be of interest to address
the endocytic competence of the vpt mutants.
We identified many new genes whose products are in-
volved in the process of vacuolar protein targeting. We
expect that many of the gene products act directly in the
targeting and transport of molecules to the yeast vacuole.
More detailed information about how the vacuolar targeting
pathway operates is anticipated on cloning of the VPT genes
and detailed biochemical characterization of the gene prod-
ucts.
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